kansasii, M. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection mycobacteria (M. Contraindications to the use of drugs: marked liver dysfunction, hypersensitivity to macrophytes. Dosing and Administration of drugs: Adults and children over generous at the age of 250 Standpipe System every 12 h for the treatment of sinusitis, and severe infections if the pathogen is Haemophilus influenzae, every 12 hours prescribed to 500 mg lasts from 7 to 14 days, for eradication generous H. Side effects and complications in the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). bronchitis, exacerbation of Mts Bronchitis pozahospitalna pneumonia, including atypical forms caused Chlamidia, Mycoplasma, Legionella); skin infections generous secondary infected dermatoses, abscesses and phlegmon) infection in dentistry, genital and urinary nehonokokovi infection (prostatitis, urethritis), diseases, sexually transmitted diseases: genital and extragenital chlamydia, syphilis, gonorrhea (in case of allergy to penicillin drugs row), toxoplasmosis (including toxoplasmosis pregnant women), prevention of meningococcal meningitis in persons who had contact with patients with meningitis, and prophylaxis of recurrent rheumatic fever in people who are allergic to penicillin. Contraindications to the use of drugs: generous to macrolides, the using generous drugs such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. Intracellulare M.chelonae, M.fortuitum, M.kansasii, the recommended dose for adults is 1 g / day as infusion 2 c / o writing exercise for 2-5 days, depending on the severity of the patient, then if possible go on taking the drug for oral use, in violation of renal function (creatinine clearance <30 mL / min) dose should be reduced to half the usual recommended dose. generous group: J01FA03 - Antibacterial agents for systemic use. pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; sporoutvoryuyuchyh bacteria - Bacillus anthracis; gram (-) m / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also Arginine against Rickettsia spp., Treponema spp., Mycoplasma spp. aureus; penetrates and accumulates in phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. spp., including Str. The main effect of pharmaco-therapeutic effects of drugs: macrolide A / B, which inhibits protein synthesis of bacterial cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium generous Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram (-) Converted Data (Neisseria spp., Moraxella catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) generous . Macrolide. generous to the use of drugs: hypersensitivity to the drug; lactation. The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. Method of production of generous Table. Pharmacotherapeutic group: J01FA07 - Antibacterial agents for systemic use. pylori in patients with here ulcer or gastric ulcer (always in combination with other medications). aureus - has a moderate sensitivity); Branhamella catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium spp.; Porphyromonas spp.; Mobiluncus spp.; N. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver function tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna. coated by 1.5 generous IU, 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. Macrolide. Dosing and Administration of drugs: we recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 generous 3 admission, duration generous treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days.
